rs1555873985
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_172107.4(KCNQ2):c.430C>G(p.Arg144Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R144Q) has been classified as Pathogenic.
Frequency
Consequence
NM_172107.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ2 | NM_172107.4 | c.430C>G | p.Arg144Gly | missense_variant | 3/17 | ENST00000359125.7 | NP_742105.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ2 | ENST00000359125.7 | c.430C>G | p.Arg144Gly | missense_variant | 3/17 | 1 | NM_172107.4 | ENSP00000352035 | A1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
KCNQ2-related disorder Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Dec 06, 2019 | The KCNQ2 c.430C>G (p.Arg144Gly) variant is a missense variant that has been reported in a heterozygous state in one affected individual with a Rett-like phenotype (Vidal et al. 2019). The affected individual is specifically noted to have psychomotor delay and intellectual disability, but no developmental regression or breathing problems; no additional phenotypes were described. The p.Arg144Gly variant is not found in the Genome Aggregation Database despite good sequence coverage, so the variant is presumed to be rare. Two additional variants at the Arg144 residue have been described in literature, including p.Arg144Gln in an infant who presented with infantile spasms without seizures, global developmental delays, poor eye contact, no speech, inability to walk, and bilateral enlarged kidneys were also noted (Epi4K Consortium et al. 2013). The second variant at the Arg144 residue was identified in an affected individual with intellectual disability, but no additional phenotypes were described (Lelieveld et al. 2016). The p.Arg144Gly variant is located in the third segment of the transmembrane domain (Vidal et al. 2019). Based on the de novo state, absence from population frequency databases, and additional clinical evidence for the Arg144 residue, the p.Arg144Gly variant is classified as likely pathogenic for KCNQ2-related disorders. - |
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This variant has been previously reported as heterozygous, unknown inheritance, in a patient with Rett-like syndrome (PMID: 31105003). Two other missense changes affecting the same amino acid residue have been reported as de novo changes in patients with neurodevelopmental disorders (c.430C>T (p.Arg144Trp); PMID: 28628100) and seizure disorders including epileptic encephalopathy and infantile spasms (c.431G>A (p.Arg144Gln); PMID: 23934111, 29186148, 30174244). It is absent from the gnomAD population database and thus is presumed to be rare. The c.430C>G (p.Arg144Gly) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.430C>G (p.Arg144Gly) variant is classified as Pathogenic. - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2017 | - - |
Developmental and epileptic encephalopathy, 7 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Nov 09, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at